πŸ’Š AI for Drug Discovery

DrugCLIP: Contrastive Learning Meets Virtual Screening

A novel contrastive learning framework that aligns molecular and protein representations for accelerated virtual drug screening, achieving state-of-the-art performance across 14 benchmark datasets.

14
Benchmark Datasets
SOTA
Performance Achieved
8.3M
Molecules in Training Set
50x
Faster Than Docking

Advancing AI-Driven Drug Discovery

DrugCLIP introduces several novel contributions to molecular representation learning and virtual screening.

πŸ”—

Contrastive Molecular Alignment

Novel cross-modal contrastive objective that jointly trains SMILES and graph-based molecular encoders with protein pocket representations.

πŸ“Š

Comprehensive Benchmark Suite

Standardized evaluation across 14 datasets spanning ADMET, binding affinity, toxicity, and activity prediction with unified metrics and protocols.

🧬

Multi-Scale Molecular Features

Hierarchical representation capturing atom-level, fragment-level, and global molecular semantics through a novel graph transformer architecture.

⚑

Zero-Shot Transfer Learning

Pre-trained representations transfer effectively to unseen protein targets without fine-tuning, enabling rapid screening of novel therapeutic areas.

🎯

Binding Affinity Prediction

Direct prediction of binding affinities from contrastive embeddings, rivaling physics-based docking methods at a fraction of the computational cost.

πŸ”„

Active Learning Pipeline

Integrated uncertainty-aware active learning loop that iteratively selects the most informative molecules for wet-lab validation, reducing experimental cycles.

Technical Framework

DrugCLIP's architecture combines advances in contrastive learning, graph neural networks, and protein language models.

🧠 Contrastive Learning (CLIP-style)
πŸ•ΈοΈ Graph Neural Networks
πŸ“ SMILES Transformer
🧬 ESM-2 Protein LM
βš—οΈ RDKit Molecular Toolkit
πŸ”₯ PyTorch + PyG
πŸ“Š MoleculeNet Benchmark
☁️ Multi-GPU Training
🐳 Docker Reproducibility
πŸ“ˆ WandB Experiment Tracking

From Bench to Bedside

DrugCLIP accelerates multiple stages of the drug discovery pipeline.

🎯 Hit Identification

Rapidly screen ultra-large virtual libraries (billions of compounds) against novel protein targets to identify promising hit molecules for further optimization.

πŸ§ͺ ADMET Property Prediction

Predict absorption, distribution, metabolism, excretion, and toxicity properties early in the pipeline to prioritize drug-like candidates and reduce attrition.

πŸ”¬ Lead Optimization

Guide medicinal chemistry by predicting how structural modifications affect binding affinity and selectivity, accelerating the lead optimization cycle.

Access DrugCLIP Resources

From open-source code to enterprise API access, choose the level of access that fits your research needs.

Starter
Free
For academic researchers
  • Open-source code & weights
  • Pre-trained model download
  • Basic benchmark results
  • Community forum access
  • Documentation & tutorials
Download Free
Enterprise
Custom
For large pharma & CROs
  • Dedicated inference clusters
  • Custom model architectures
  • On-premise deployment
  • Active learning integration
  • Dedicated research liaison
  • Co-publication opportunities
Contact Us
@article{drugclip2025,
  title={DrugCLIP: Contrastive Learning for Virtual Drug Screening},
  author={drugclip-paper Research Team},
  journal={arXiv preprint},
  year={2025}
}

Accelerate Your Drug Discovery Research

Access the DrugCLIP model, benchmark suite, and codebase to bring AI-powered virtual screening into your research pipeline.

Ready to get started?

Join leading organizations using drugclip-paper

Get Started Free